Rehan Verjee - 14 Sep 2021 Form 3 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role
Director
Signature
/s/ John Healy, Attorney-in Fact
Issuer symbol
TYRA
Transactions as of
14 Sep 2021
Net transactions value
$0
Form type
3
Filing time
14 Sep 2021, 21:21:06 UTC
Next filing
15 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TYRA Stock Option (Right to Buy) 14 Sep 2021 Common Stock 67,467 $7.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the shares subject to the option vest monthly following June 2, 2021, the vesting commencement date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney